We are live on ! Find out more
HA

Harborview Advisors Portfolio holdings

AUM $179M
1-Year Est. Return 23.7%
This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+23.7%
3 Year Est. Return
+27.1%
5 Year Est. Return
10 Year Est. Return
AUM
$124M
AUM Growth
+$687K
Cap. Flow
+$893K
Cap. Flow %
0.72%
Top 10 Hldgs %
63.32%
Holding
87
New
4
Increased
22
Reduced
46
Closed
2

Sector Composition

Rank Sector Weight
1 Healthcare 1.01%
2 Technology 0.93%
3 Consumer Discretionary 0.29%
4 Communication Services 0.28%
5 Industrials 0.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VWO icon
76
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$232K 0.19%
5,762
-73
-1% -$3.01K
VPL icon
77
Vanguard FTSE Pacific ETF
VPL
$8.08B
$224K 0.18%
3,389
-132
-4% -$8.58K
CVS icon
78
CVS Health
CVS
$133B
$221K 0.18%
+3,503
New +$208K
IJH icon
79
iShares Core S&P Mid-Cap ETF
IJH
$122B
$211K 0.17%
5,465
WDIV icon
80
State Street SPDR S&P Global Dividend ETF
WDIV
$277M
$209K 0.17%
+3,102
New +$206K
IGA
81
Voya Global Advantage and Premium Opportunity Fund
IGA
$157M
$149K 0.12%
14,369
-1,246
-8% -$13.1K
NFJ
82
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.41B
$124K 0.1%
10,148
-2,735
-21% -$33.7K
BGY icon
83
BlackRock Enhanced International Dividend Trust
BGY
$524M
$112K 0.09%
+20,600
New +$113K
BDJ icon
84
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
$102K 0.08%
11,082
-4,161
-27% -$37.4K
CDMO
85
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$64K 0.05%
12,124
FBT icon
86
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
-1,441
Closed -$203K
FLRN icon
87
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.08B
-171,962
Closed -$5.28M

Similar funds

Harborview Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Harborview Advisors held 87 positions worth $124M, up 0.56% from $124M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Harborview Advisors's Q3 2019 filing shows 4 new, 22 increased, 46 reduced and 2 closed positions. Its largest new stake was Pfizer: 6,901 shares worth $235K. The largest sale was State Street SPDR Bloomberg Investment Grade Floating Rate ETF, an estimated $5.28M.

By sector, the portfolio is most concentrated in Healthcare at 1% of assets, up from 0.64% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Harborview Advisors's largest Q3 2019 buy was Pfizer: 6,901 shares worth $235K.
  • Harborview Advisors added most to WisdomTree Trust WisdomTree Interest Rate Hedged US Aggregate Bond Fund in Q3 2019, an estimated $5.32M increase.
  • Harborview Advisors's biggest Q3 2019 reduction was Schwab US Large-Cap Growth ETF, cutting an estimated $425K.
  • Harborview Advisors fully exited State Street SPDR Bloomberg Investment Grade Floating Rate ETF in Q3 2019, selling an estimated $5.28M.
  • Harborview Advisors's ten largest holdings make up 63% of its $124M portfolio in Q3 2019.
  • Harborview Advisors opened 4 new positions and closed 2 in Q3 2019.
  • Harborview Advisors's portfolio value rose 0.56% quarter-over-quarter to $124M.

Based on Harborview Advisors's 13F filing for Q3 2019, filed 22 Oct 2019.